You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
| Title |
Phase III Trial of Chemotherapy Plus Radiotherapy Compared With Radiotherapy Alone for Pure and Mixed Anaplastic Oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402
|
|---|---|
| Published in |
Journal of Clinical Oncology, June 2006
|
| DOI | 10.1200/jco.2005.04.3414 |
| Pubmed ID | |
| Authors |
Gregory Cairncross, Brian Berkey, Edward Shaw, Robert Jenkins, Bernd Scheithauer, David Brachman, Jan Buckner, Karen Fink, Luis Souhami, Normand Laperierre, Minesh Mehta, Walter Curran |
| Abstract |
Anaplastic oligodendroglioma (AO) and anaplastic oligoastrocytoma (AOA) are treated with surgery and radiotherapy (RT) at diagnosis, but they also respond to procarbazine, lomustine, and vincristine (PCV), raising the possibility that early chemotherapy will improve survival. Furthermore, better outcomes in AO have been associated with 1p and 19q allelic loss. |
Mendeley readers
The data shown below were compiled from readership statistics for 271 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 4 | 1% |
| Japan | 3 | 1% |
| Germany | 1 | <1% |
| Australia | 1 | <1% |
| Brazil | 1 | <1% |
| India | 1 | <1% |
| Nepal | 1 | <1% |
| Canada | 1 | <1% |
| France | 1 | <1% |
| Other | 2 | <1% |
| Unknown | 255 | 94% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 47 | 17% |
| Other | 40 | 15% |
| Student > Postgraduate | 27 | 10% |
| Student > Ph. D. Student | 25 | 9% |
| Student > Master | 23 | 8% |
| Other | 71 | 26% |
| Unknown | 38 | 14% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 159 | 59% |
| Agricultural and Biological Sciences | 21 | 8% |
| Neuroscience | 11 | 4% |
| Biochemistry, Genetics and Molecular Biology | 7 | 3% |
| Nursing and Health Professions | 5 | 2% |
| Other | 16 | 6% |
| Unknown | 52 | 19% |
Attention Score in Context
This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 July 2018.
All research outputs
#2,117,293
of 22,649,029 outputs
Outputs from Journal of Clinical Oncology
#4,899
of 19,837 outputs
Outputs of similar age
#4,005
of 63,833 outputs
Outputs of similar age from Journal of Clinical Oncology
#20
of 142 outputs
Altmetric has tracked 22,649,029 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 19,837 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 19.2. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 63,833 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 142 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.